Giving What We Can is an international society dedicated to eliminating poverty in the developing world by helping people make smart decisions about donating to charitable causes.

Doctors Without Borders/Médecins Sans Frontières (MSF), the Drugs for Neglected Disease initiative (DNDi) and the Mount Sinai School of Medicine’s Global Health program will host a conference to discuss past medical advances and future global health needs as research and development for

Today marks the first day of vaccinations for Phase I, Part II clinical testing of Sabin's human hookworm vaccine in Brazil.

Congratulations to WIPO Re:Search on its one year anniversary!
The recent West Nile Virus outbreaks in Texas and across the United States have called attention to the strong links between tropical diseases and poverty, both in the United States and abroad. In an editorial published in the Sunday, September 2 edition of the Houston Chronicle, Dr. Hotez and his co-author, Dr. Kristy Murray of Baylor College of Medicine, called for more disease surveillance, education for healthcare providers and greater engagement by product development partnerships such as the Sabin PDP to respond to these urgent public health issues:
A debate is emerging about the potential use of genetically modified (GM) mosquitoes to combat dengue in the United States and in other countries around the world. Most recently, news out of Brazil indicated that the country plans to breed GM mosquitoes to stop the spread of dengue.
Brazil’s health ministry recently announced its plan to breed genetically modified mosquitoes to stop the spread of dengue fever. According to news reports, scientists are focusing intensely on mosquito control because there is currently no vaccine to protect against dengue.
The Centers for Disease Control and Prevention recently announced its development of a new diagnostic test to detect the presence of the dengue virus.

This month, the Sabin Vaccine Institute will begin a Phase-1 clinical trial in Washington, DC to further investigate the Na-GST-1 human hookworm vaccine candidate.

Each year since 1994 the Sabin Vaccine Institute has  recognized distinguished members of the scientific community  with its highest honor, the Albert B. Sabin Gold Medal Award.  Gold Medal Award winners have made significant contributions  to vaccinology or a complementary field.

Pages